Dr. Michael J. Thirman M.D.
Hematologist-Oncologist | Hematology & Oncology
5841 S Maryland Ave Section Of Hematolog Chicago IL, 60637About
Dr. Michael Thirman specializes in the medical management of adults with leukemia, lymphoma, myelodysplastic syndromes, and myeloproliferative disorders. His laboratory focuses on the role of MLL and ...
Education and Training
Univ of Mi Med Sch, Ann Arbor Mi 1986
University of Michigan Medical School 1986
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice.
- EAF1, a novel ELL-associated factor that is delocalized by expression of the MLL-ELL fusion protein.
- The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesis.
- The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis.
- ELL-associated factor 2 (EAF2), a functional homolog of EAF1 with alternative ELL binding properties.
- ELL and EAF1 are Cajal body components that are disrupted in MLL-ELL leukemia.
- The elongation factor ELL (eleven-nineteen lysine-rich leukemia) is a selective coregulator for steroid receptor functions.
- Apoptosis induction and growth suppression by U19/Eaf2 is mediated through its ELL-binding domain.
- Methylation-independent silencing of the tumor suppressor INK4b (p15) by CBFbeta-SMMHC in acute myelogenous leukemia with inv(16).
- Successful autologous stem cell collection in patients with chronic myeloid leukemia in complete cytogenetic response, with quantitative measurement of BCR-ABL expression in blood, marrow, and apheresis products.
- Loss of MLL PHD finger 3 is necessary for MLL-ENL-induced hematopoietic stem cell immortalization.
- Consistent deregulation of gene expression between human and murine MLL rearrangement leukemias.
- Dynamic bookmarking of primary response genes by p300 and RNA polymerase II complexes.
- Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia.
- MLL fusion proteins preferentially regulate a subset of wild-type MLL target genes in the leukemic genome.
Clinical Trials
Treatments
- Blood Cancers, Leukemia, Lymphoma And More
- Anemia
- Acute Myeloid Leukemia (aml)
- Leukemia
- Dermal Aesthetics
- Oral Surgery Procedures
- Extra Corporeal Shockwave Therapy
Professional Memberships
- Member American Society of Hematology
Dr. Michael J. Thirman M.D.'s Practice location
Dr. Michael J. Thirman M.D.'s reviews
Write ReviewPatient Experience with Dr. Thirman
Recommended Articles
- 9/11 Ground Zero Worker's Lymphoma Improves with Clinical Trial
When the terrorist attacks occurred in New York on September 11th, 2001, Bart Zagami, a 61-year-old New York State Supreme Court officer, was in his office just a few blocks away from the World Trade Center in lower Manhattan. Days after the 9/11 terrorist attacks, Zagami spent his time at Ground...
- New Diagnostic Tool Approved for Lymphoma
A new diagnostic tool has been approved by the U.S. Food and Drug Administration (FDA) to help researchers identify leukemia and lymphoma cells by using a technique known as flow cytometry. A flow cytometry test for non-Hodgkin’s lymphoma (NHL) can help determine whether normal or abnormal DNA is...
- Promising Results for Hodgkin Patients Using This Therapy
Researcher Dr. Bradford S. Hoppe and his colleagues at the University of Florida College of Medicine have recently found that the addition of proton therapy to first-line chemotherapy regimens may improve outcomes for patients with Hodgkin lymphoma.Lymphoma is classically treated with both...
- Exercise Proven to Help Lymphoma Patients
People always say that exercise is the best medicine. It's been proven through many years of research that regular exercise is really important to maintain a healthy body and mind. Doctors are always reminding their patients of the benefits of physical exercise and the power it holds to fight...
- How to Deal with Lymphoma Treatment Fatigue
Treatment fatigue is a very common problem among lymphoma patients. Whether the patient is doing pharmaceutical treatments, chemotherapy, or other treatments, they will likely lead to fatigue and a feeling of being burnt out.This article will go over what treatment fatigue is, symptoms that are...
- Teen Treated for Lymphoma to Play College Baseball
Whether it’s the Dodgers or the Red Sox or the local high school team, they’re called ‘the boys of summer’.While summer is when the teams begin competitive play, they are very much the boys of spring as well.The temperature might be cool, but the air is sweet with promise.The players pull...
Nearby Providers
- Dr. Akash Patnaik M.D., PH.D.5841 S MARYLAND AVE CHICAGO IL 60637
- Dr. Andrew Saul Artz M.D., M.S.5841 S Maryland Ave Chicago IL 60637
- Dr. Justin Paul Kline M.D.5841 S Maryland Ave Chicago IL 60637
- Dr. Elias I Obeid M.D., MPH5841 S Maryland Ave Chicago IL 60637
- Dr. Walter M Stadler MD5841 S Maryland Ave Chicago IL 60637
- Dr. Sunil Narula MD5841 S MARYLAND AVE CHICAGO IL 60637